This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marchetti, D. Articles by Shen, R. Search for Related Content PubMed PubMed Citation Articles by Marchetti, D. Articles by Shen, R.

Astrocytes Contribute to the Brain-metastatic Specificity of Melanoma Cells by Producing Heparanase¹

Department of Neurosurgery, The University of Texas-Houston Health Science Center [D. M., R. S.], and Laboratory Medicine, M. D. Anderson Cancer Center [J. L.], Houston, Texas 77030

Neurotrophins (NTs) modulate the brain invasion of melanoma cells and the activity of an extracellular matrix degradative enzyme, heparanase, that has been recently cloned. Heparanase degrades the heparan sulfate proteoglycans (HSPGs) and is a critical mediator of tumor metastasis and angiogenesis. Because astrocytes are among the first brain cells encountered by extravasating melanoma cells, they may play important roles in the development of brain metastases. To test this hypothesis, we used purified in vitro astrocyte cultures and found that they express heparanase transcript and functional enzyme that were up-regulated by the prototypic NT, nerve growth factor. Coincubation of astrocytes (or their conditioned medium) with brain-metastatic cells resulted in a superadditive effect on heparanase activity and up to an 8-fold increase of in vitro chemoinvasion using purified HSPGs. These observations indicate that astrocytes significantly contribute to the brain colonization of melanoma cells via heparanase-driven modalities.

This article has been cited by other articles:

				N. Sommerfeldt, P. Beckhove, Y. Ge, F. Schutz, C. Choi, M. Bucur, C. Domschke, C. Sohn, A. Schneeweis, J. Rom, et al. Heparanase: a new metastasis-associated antigen recognized in breast cancer patients by spontaneously induced memory T lymphocytes. Cancer Res., August 1, 2006; 66(15): 7716 - 7723. [Abstract] [Full Text] [PDF]

				T. Kelly, L. J. Suva, Y. Huang, V. MacLeod, H.-Q. Miao, R. C. Walker, and R. D. Sanderson Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases Cancer Res., July 1, 2005; 65(13): 5778 - 5784. [Abstract] [Full Text] [PDF]

				Y. Yang, V. MacLeod, M. Bendre, Y. Huang, A. M. Theus, H.-Q. Miao, P. Kussie, S. Yaccoby, J. Epstein, L. J. Suva, et al. Heparanase promotes the spontaneous metastasis of myeloma cells to bone Blood, February 1, 2005; 105(3): 1303 - 1309. [Abstract] [Full Text] [PDF]

				Y. Denkins, J. Reiland, M. Roy, N. D. Sinnappah-Kang, J. Galjour, B. P. Murry, J. Blust, R. Aucoin, and D. Marchetti Brain metastases in melanoma: Roles of neurotrophins Neuro-oncol, April 1, 2004; 6(2): 154 - 165. [Abstract] [PDF]

				N. Sasaki, N. Higashi, T. Taka, M. Nakajima, and T. Irimura Cell Surface Localization of Heparanase on Macrophages Regulates Degradation of Extracellular Matrix Heparan Sulfate J. Immunol., March 15, 2004; 172(6): 3830 - 3835. [Abstract] [Full Text] [PDF]

				J. Reiland, R. D. Sanderson, M. Waguespack, S. A. Barker, R. Long, D. D. Carson, and D. Marchetti Heparanase Degrades Syndecan-1 and Perlecan Heparan Sulfate: FUNCTIONAL IMPLICATIONS FOR TUMOR CELL INVASION J. Biol. Chem., February 27, 2004; 279(9): 8047 - 8055. [Abstract] [Full Text] [PDF]

				T. Kelly, H.-Q. Miao, Y. Yang, E. Navarro, P. Kussie, Y. Huang, V. MacLeod, J. Casciano, L. Joseph, F. Zhan, et al. High Heparanase Activity in Multiple Myeloma Is Associated with Elevated Microvessel Density Cancer Res., December 15, 2003; 63(24): 8749 - 8756. [Abstract] [Full Text] [PDF]

				X. Xu, R. M. Quiros, J. B. Maxhimer, P. Jiang, R. Marcinek, K. B. Ain, J. L. Platt, J. Shen, P. Gattuso, and R. A. Prinz Inverse Correlation between Heparan Sulfate Composition and Heparanase-1 Gene Expression in Thyroid Papillary Carcinomas: A Potential Role in Tumor Metastasis Clin. Cancer Res., December 1, 2003; 9(16): 5968 - 5979. [Abstract] [Full Text] [PDF]

				L. Nadav, A. Eldor, O. Yacoby-Zeevi, E. Zamir, I. Pecker, N. Ilan, B. Geiger, I. Vlodavsky, and B.-Z. Katz Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts J. Cell Sci., May 15, 2002; 115(10): 2179 - 2187. [Abstract] [Full Text] [PDF]

				F. Uno, T. Fujiwara, Y. Takata, S. Ohtani, K. Katsuda, M. Takaoka, T. Ohkawa, Y. Naomoto, M. Nakajima, and N. Tanaka Antisense-mediated Suppression of Human Heparanase Gene Expression Inhibits Pleural Dissemination of Human Cancer Cells Cancer Res., November 1, 2001; 61(21): 7855 - 7860. [Abstract] [Full Text] [PDF]

				A. Koliopanos, H. Friess, J. Kleeff, X. Shi, Q. Liao, I. Pecker, I. Vlodavsky, A. Zimmermann, and M. W. Buchler Heparanase Expression in Primary and Metastatic Pancreatic Cancer Cancer Res., June 1, 2001; 61(12): 4655 - 4659. [Abstract] [Full Text] [PDF]

				O. Goldshmidt, E. Zcharia, H. Aingorn, Z. Guatta-Rangini, R. Atzmon, I. Michal, I. Pecker, E. Mitrani, and I. Vlodavsky Expression Pattern and Secretion of Human and Chicken Heparanase Are Determined by Their Signal Peptide Sequence J. Biol. Chem., July 27, 2001; 276(31): 29178 - 29187. [Abstract] [Full Text] [PDF]